Addressing Antimicrobial Resistance and Stewardship: The Priority Antimicrobial Value and Entry (PAVE) Award

JAMA. 2017 Sep 26;318(12):1103-1104. doi: 10.1001/jama.2017.10164.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Infective Agents / economics*
  • Anti-Infective Agents / therapeutic use
  • Drug Discovery / economics*
  • Drug Resistance, Microbial*
  • Humans
  • Risk Sharing, Financial*
  • United States
  • Value-Based Health Insurance

Substances

  • Anti-Infective Agents